Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: bioMérieux

Capitalization 11.45B 12.03B 10.66B 9.5B 16.93B 1,019B 18.58B 133B 49.15B 418B 45.21B 44.2B 1,799B P/E ratio 2024 *
24.4x
P/E ratio 2025 * 21.5x
Enterprise value 11.37B 11.95B 10.59B 9.44B 16.81B 1,012B 18.45B 132B 48.81B 415B 44.9B 43.89B 1,787B EV / Sales 2024 *
2.88x
EV / Sales 2025 * 2.63x
Free-Float
36.04%
Yield 2024 *
0.93%
Yield 2025 * 1.05%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.88%
1 week-3.66%
Current month-2.73%
1 month-6.56%
3 months-6.65%
6 months+0.10%
Current year-4.42%
More quotes
1 week
95.90
Extreme 95.9
100.10
1 month
95.90
Extreme 95.9
104.50
Current year
88.25
Extreme 88.25
111.50
1 year
88.25
Extreme 88.25
111.50
3 years
77.48
Extreme 77.48
129.60
5 years
75.00
Extreme 75
144.80
10 years
27.13
Extreme 27.1333
144.80
More quotes
Director TitleAgeSince
Chief Executive Officer 53 30/06/2023
Director of Finance/CFO 48 28/02/2018
Chief Tech/Sci/R&D Officer - 01/01/2024
Manager TitleAgeSince
Chairman 75 31/12/2013
Chairman 50 14/12/2017
Director/Board Member 64 31/12/2004
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.88%-3.66%-4.66%-16.43%12.03B
-0.22%+8.02%-5.25%+56.36%7.42B
-1.19%-1.14%+19.95%+234.00%6.15B
-0.29%-2.99%+21.72%-39.73%5.84B
+0.73%+4.10%+35.89%-60.55%4.42B
-0.69%+1.73%-14.02%-15.79%3.61B
+0.86%-0.71%+22.70%-53.05%2.73B
-1.97%-0.63%+14.80%+118.51%2.71B
-3.95%+5.40%-65.42%-88.53%1.92B
+1.39%+9.41%+28.79%-34.96%1.89B
Average -0.62%+1.69%+5.45%+9.98% 4.87B
Weighted average by Cap. -0.58%+0.83%+6.03%+21.44%
See all sector performances

Financials

2024 *2025 *
Net sales 3.95B 4.15B 3.68B 3.28B 5.84B 352B 6.41B 45.72B 16.95B 144B 15.59B 15.24B 620B 4.23B 4.45B 3.94B 3.52B 6.26B 377B 6.88B 49.05B 18.18B 155B 16.73B 16.35B 666B
Net income 474M 499M 442M 394M 702M 42.24B 770M 5.49B 2.04B 17.32B 1.87B 1.83B 74.56B 536M 564M 500M 445M 793M 47.77B 871M 6.21B 2.3B 19.59B 2.12B 2.07B 84.32B
Net Debt -79M -83.04M -73.58M -65.59M -117M -7.03B -128M -915M -339M -2.88B -312M -305M -12.42B -312M -328M -291M -259M -461M -27.78B -507M -3.61B -1.34B -11.39B -1.23B -1.2B -49.04B
More financial data * Estimated data
Logo bioMérieux
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.6%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).
Employees
13,696
Calendar
More about the company
Date Price Change Volume
04/12/24 97.30 +0.31% 66,683
03/12/24 97.00 -0.51% 83,033
02/12/24 97.50 -1.37% 81,422
29/11/24 98.85 -0.20% 60,752
28/11/24 99.05 -0.75% 36,884

Real-time Euronext Paris, December 04, 2024 at 10:59 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart BIOMERIEUXMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
97.00EUR
Average target price
117.95EUR
Spread / Average Target
+21.59%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW